Julie Donaghey

I completed my undergraduate studies in biology at Boston University where I conducted muscular skeletal research in Francisco Naya’s laboratory studying the Duchene Muscular Dystrophy (DMD) gene.

I took a few years off between undergrad and graduate school and first worked for a start-up drug discovery biotech, called Syndex, where we were trying to develop a pharmaceutical to treat Type II Diabetes and inflammatory diseases. From there, I became a research technician in Eric Lander’s laboratory at the Broad Institute studying long non-coding RNAs (lnRNAs) with Mitchell Guttman and John Rinn.

My long-term research interests involve using genomics to understand the mechanisms of cell fate conversion with an emphasis on understanding how transcription factors overcome epigenetic obstacles to access target sites in chromatin to cause novel transcriptional changes.